Levosulpiride

左舒必利

Report date: 2022/01/17 12:14:22
NME

Base Information

Drug NameLevosulpiride
Drug Alias NameLsulpiride左旋舒必利LevobrenLevosulpridelevosulpiridum +[10
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors antagonists
TargetsDopamine receptors
Therapy Area/IndicationsSchizophreniaMental DisordersDepression +[12
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active IndicationsSchizophreniaMental Disorders
Inactive IndicationsDepressionVomitingEructation +[10

Other Information

ATC CodeN05AL07